|
US4145406A
(en)
|
1977-04-11 |
1979-03-20 |
Miles Laboratories, Inc. |
Specific binding - adsorbent assay method and test means
|
|
US4254082A
(en)
|
1978-06-12 |
1981-03-03 |
Miles Laboratories, Inc. |
Specific binding-adsorbent assay test means
|
|
CA1247538A
(en)
|
1982-05-21 |
1988-12-28 |
Mark C. Glassy |
Human-human hybridomas for solid tumors
|
|
US4687732A
(en)
|
1983-06-10 |
1987-08-18 |
Yale University |
Visualization polymers and their application to diagnostic medicine
|
|
US4690890A
(en)
|
1984-04-04 |
1987-09-01 |
Cetus Corporation |
Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
|
|
JPS60248618A
(ja)
|
1984-05-24 |
1985-12-09 |
Nippon Zoki Pharmaceut Co Ltd |
ジペプチドを含有する潰瘍治療剤
|
|
US4792521A
(en)
|
1985-08-15 |
1988-12-20 |
Immunomedics, Inc. |
Non-enzymatic immunohistochemical staining system and reagents
|
|
US4863875A
(en)
|
1985-08-26 |
1989-09-05 |
Gia Research Company, L.P. |
Dye labelled antibodies as reagents for use in immunoassay systems
|
|
GB8607101D0
(en)
|
1986-03-21 |
1986-04-30 |
Serono Diagnostics Ltd |
Immunoassay
|
|
US5089423A
(en)
|
1987-05-06 |
1992-02-18 |
Cyberfluor Inc. |
Immunoassay methods and reagents and methods for producing the latter
|
|
US5620845A
(en)
|
1988-06-06 |
1997-04-15 |
Ampcor, Inc. |
Immunoassay diagnostic kit
|
|
US5252487A
(en)
|
1989-05-19 |
1993-10-12 |
Cell Analysis Systems, Inc. |
Method and apparatus for determining the amount of oncogene protein product in a cell sample
|
|
US5719063A
(en)
|
1989-08-25 |
1998-02-17 |
Boehringer Mannheim Corporation |
Multiplex immunoassay system
|
|
US6008057A
(en)
|
1989-08-25 |
1999-12-28 |
Roche Diagnostics Corporation |
Immunoassay system
|
|
EP0513332A4
(en)
|
1990-11-14 |
1993-03-17 |
Cargill, Incorporated |
Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US5280108A
(en)
*
|
1991-09-27 |
1994-01-18 |
United States Of America |
Antibodies to p40
|
|
MD1367C2
(ro)
|
1992-11-13 |
2000-11-30 |
Idec Pharmaceuticals Corporation |
Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
|
|
US5482698A
(en)
|
1993-04-22 |
1996-01-09 |
Immunomedics, Inc. |
Detection and therapy of lesions with biotin/avidin polymer conjugates
|
|
US5487975A
(en)
|
1993-11-15 |
1996-01-30 |
Ventana Medical Systems, Inc. |
Biotin/avidin formulation
|
|
ATE203274T1
(de)
|
1994-02-01 |
2001-08-15 |
Nasa |
Fusionierte proteine die antikörper-teile und nicht-antikörper-teile enthalten
|
|
US5869274A
(en)
|
1995-08-09 |
1999-02-09 |
Zymed Laboratories, Inc. |
Immuno-histochemical method that reduces background staining
|
|
US5891658A
(en)
|
1996-06-27 |
1999-04-06 |
FCI--FiberChem, Inc. |
Single-step, solid-state competitive immunoassay
|
|
EP2107109B1
(en)
|
1996-08-23 |
2012-06-20 |
Vegenics Pty Ltd |
Recombinant vascular endothelial cell growth factor D (VEGF-D)
|
|
US7196164B2
(en)
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
|
WO1999015901A1
(en)
|
1997-09-22 |
1999-04-01 |
Chiron Corporation |
Buffers for stabilizing antigens
|
|
US7294459B1
(en)
|
1997-10-15 |
2007-11-13 |
President And Fellows Of Harvard College |
Cell regulatory genes, encoded products, and uses related thereto
|
|
US6476206B1
(en)
*
|
1998-03-27 |
2002-11-05 |
The Johns Hopkins University |
p40 protein acts as an oncogene
|
|
JP3524401B2
(ja)
|
1998-09-16 |
2004-05-10 |
株式会社ニチレイ |
酵素抗体複合体およびその製造方法
|
|
JP4056701B2
(ja)
|
1999-05-14 |
2008-03-05 |
ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア |
薬剤および診断薬の送達のための高分子担体
|
|
US6723506B2
(en)
|
2000-01-20 |
2004-04-20 |
Brigham And Women's Hospital |
Method of identifying PAX8-PPAR gamma-nucleic acid molecules
|
|
US20030017491A1
(en)
|
2000-09-14 |
2003-01-23 |
Zuo-Rong Shi |
Chromogenic in situ hybridization methods, kits, and compositions
|
|
DE10063179A1
(de)
|
2000-12-18 |
2002-06-20 |
Bayer Ag |
Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20020173053A1
(en)
|
2001-04-27 |
2002-11-21 |
Bassam Damaj |
Multiple simultaneous antigen detection by immunohistochemistry
|
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
|
US6580056B1
(en)
|
2001-09-21 |
2003-06-17 |
Biocare Medical |
Biological specimen heating device and quality control method for immunohistochemistry heat retrieval procedures
|
|
EP1480520A4
(en)
|
2002-02-12 |
2006-02-15 |
Raven Biotechnologies Inc |
EPITHELIAL CELLS FROM THE HUMAN FOLDS BUBBLE
|
|
MY154009A
(en)
|
2002-03-13 |
2015-04-30 |
Biogen Idec Inc |
Anti-alpha v beta 6 antibodies
|
|
US7850912B2
(en)
*
|
2003-05-14 |
2010-12-14 |
Dako Denmark A/S |
Method and apparatus for automated pre-treatment and processing of biological samples
|
|
US7354584B2
(en)
|
2003-04-11 |
2008-04-08 |
Medimmune, Inc. |
Recombinant IL-9 antibodies
|
|
EP1635872A4
(en)
|
2003-05-30 |
2008-01-02 |
Alexion Pharma Inc |
ANTIBODIES AND FUSION PROTEINS COMPRISING MODIFIED CONSTANT REGIONS
|
|
WO2005054860A1
(en)
|
2003-12-01 |
2005-06-16 |
Dako Denmark A/S |
Methods and compositions for immuno-histochemical detection
|
|
WO2005076005A2
(en)
|
2004-01-30 |
2005-08-18 |
Medizinische Universität Wien |
A method for classifying a tumor cell sample based upon differential expression of at least two genes
|
|
US20050186642A1
(en)
|
2004-02-24 |
2005-08-25 |
Biocare Medical, Inc. |
Immunoassay reagents and methods of use thereof
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
ES2351057T3
(es)
|
2005-07-08 |
2011-01-31 |
Pfizer Limited |
Anticuerpos contra madcam.
|
|
JP4736037B2
(ja)
|
2005-10-26 |
2011-07-27 |
株式会社イーベック |
ヒトｇｍ−ｃｓｆに結合するヒトのモノクローナル抗体並びにその抗原結合部分
|
|
ES2527661T3
(es)
*
|
2005-11-30 |
2015-01-28 |
Abbvie Inc. |
Método de exploración, proceso para purificar oligómeros Abeta no difundibles, anticuerpos selectivos contra dichos oligómeros Abeta no difundibles y un proceso para fabricar dichos anticuerpos
|
|
NZ572561A
(en)
*
|
2006-06-07 |
2012-05-25 |
Bioalliance Cv |
Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
|
|
US20100092457A1
(en)
|
2006-08-14 |
2010-04-15 |
Forerunner Pharma Research Co., Ltd. |
Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies
|
|
ES2618830T3
(es)
|
2006-12-08 |
2017-06-22 |
Lexicon Pharmaceuticals, Inc. |
Anticuerpos monoclonales contra ANGPTL3
|
|
WO2008127642A1
(en)
|
2007-04-11 |
2008-10-23 |
Enteron Limited Partnership |
Myelin specific ige unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
|
|
JP5117765B2
(ja)
|
2007-05-28 |
2013-01-16 |
国立大学法人 東京大学 |
抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
|
|
CL2008002856A1
(es)
|
2007-09-26 |
2009-01-16 |
Genentech Inc |
Anticuerpo novedoso (anticuerpo anti-integrina a5b1; mol}ecula de ácido nucleico que lo codifica; vector y célula huesped; método de producción; composición farmacéutica que lo comprende; su uso para inhibir la angiogénesis y/o permeabilidad vascular y cáncer entre otras patologías; y método de detección de la integrina a5b1).
|
|
ES2638579T3
(es)
|
2008-08-29 |
2017-10-23 |
Symphogen A/S |
Composiciones de anticuerpos recombinantes contra el receptor del factor de crecimiento epidérmico
|
|
US8927697B2
(en)
|
2008-09-12 |
2015-01-06 |
Isis Innovation Limited |
PD-1 specific antibodies and uses thereof
|
|
US7846762B2
(en)
|
2008-09-22 |
2010-12-07 |
Applied Materials, Inc. |
Integrated emitter formation and passivation
|
|
EP2425253B1
(en)
|
2009-05-01 |
2017-03-22 |
Dako Denmark A/S |
New antibody cocktail
|
|
JP2012526542A
(ja)
*
|
2009-05-12 |
2012-11-01 |
ファイザー・インク |
遮断抗ｄｋｋ−１抗体およびその使用
|
|
WO2011047019A1
(en)
|
2009-10-13 |
2011-04-21 |
Yale University |
An objective, quantitative method to predict histological subtype in non-small cell lung cancer
|
|
US20120321557A1
(en)
|
2010-02-26 |
2012-12-20 |
Forerunner Pharma Research Co., Ltd. |
Anti-icam3 antibody and use thereof
|
|
EP2402370A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Pierre Fabre Médicament |
Novel antibody for the diagnosis and/or prognosis of cancer
|
|
SG188328A1
(en)
|
2010-09-03 |
2013-04-30 |
Stem Centrx Inc |
Novel modulators and methods of use
|
|
WO2012048154A1
(en)
|
2010-10-06 |
2012-04-12 |
Biocare Medical, Llc |
Methods and systems for efficient processing of biological samples
|
|
WO2012154983A2
(en)
|
2011-05-10 |
2012-11-15 |
Biocare Medical, Llc |
Systems and methods for anti-pax8 antibodies
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
JP6324970B2
(ja)
|
2012-09-27 |
2018-05-23 |
バイオケア メディカル， エルエルシー |
抗ウロプラキンｉｉ抗体システムおよび方法
|
|
WO2014100220A2
(en)
*
|
2012-12-18 |
2014-06-26 |
Biocare Medical, Llc |
Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer
|
|
ES2720483T3
(es)
|
2013-02-28 |
2019-07-22 |
Biocare Medical Llc |
Sistemas y procedimientos de anticuerpos anti p40
|
|
EP3052522B1
(en)
|
2013-10-03 |
2019-12-11 |
Biocare Medical, LLC |
Anti-sox10 antibody systems and methods
|